Upcoming Events

Oppenheimer's Private Life Sciences Company Call Series
June 29 - July 2, 2020 - Webinar
ARTEMIS® Antibody TCR T-Cell Therapy for Solid Tumors

Past Events

Cowen 40th Annual Health Care Conference
March 1-4, 2020 - Boston Marriott Copley Place, Boston, MA
ARTEMIS® Antibody Redirected TCR Therapies for Solid Tumors

6th Annual Immuno-Oncology 360°
February 26-28, 2020 - Crowne Plaza Times Square, New York City, NY
New Scientific Frontiers in Cell Therapies for Solid Tumors

CAR-TCR Europe
February 24-27, 2020 - Hotel Novotel London West, London, UK
Translational Strategies to Prevent Toxicity

Antibody Engineering & Therapeutics
December 9-13, 2019 - Marriott Marquis San Diego, San Diego, CA
TCR-mimic Antibodies against Intracellular Target for Cancer Immunotherapy: Targeting Alpha-fetoprotein (AFP) in Advanced Hepatocellular Carcinoma

61st American Society of Hematology (ASH) Annual Meeting
December 7-10, 2019 - Orange County Convention Center (OCCC), Orlando, FL
Poster Presentation - First-in-Human Study of ET019003, a Next Generation Anti-CD19 T-Cell Therapy, in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)

World Vaccine & Immunotherapy Congress West Coast 2019
December 2-5, 2019 - San Francisco Airport Marriott Waterfront, San Francisco, CA
TCR-mimic Antibody Redirected T-cell Therapy for Solid Tumors 

The Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
November 6-10, 2019 - Gaylord National Hotel & Convention Center, National Harbor, MD
Poster Presentation - ET140202 T-cell Therapy for the Treatment of Liver Cancer is Built upon a Novel Antibody-T cell Receptor (AbTCR) ARTEMIS™ T-cell Platform

EPPICon 2019
September 28, 2019 - Santa Clara Convention Center, Santa Clara, CA
Panel Discussion - The Promise of Cell Therapy 

Precision: Blood Cancer Networking R&D Summit
September 17-18, 2019 - Crowne Plaza San Francisco Airport, San Francisco, CA
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies

CAR-TCR Summit 2019
September 10-13, 2019 - Seaport Hotel & WTC, Boston, MA
ET140202 T-Cell Therapy in Advanced Liver Cancer (Hepatocellular Carcinoma)
A Novel Antibody-T cell Receptor (AbTCR) ARTEMIS™ T-cell Platform Designed to Prevent T-Cell Hyperactivation

CAR-TCR Summit Asia 2019
June 18-20, 2019 - Shanghai, China
Antibody-TCR ARTEMIS™ T-cell Therapy for Solid Tumors & Hematological Malignancies

Next Generation CAR&T Cell Therapies
June 18-20, 2019 - Park Central Hotel, San Francisco, CA
Safety and Efficacy of TCR-mimic Technology in Hematologic and Solid Tumors

Bank of America Merrill Lynch Health Care Conference
May 13-17, 2019 - Encore Hotel, Las Vegas, NV
Antibody-TCR ARTEMIS™ T-cell Therapy for Solid Tumors & Hematological Malignancies

Asia Pharma R&D Leaders Summit 2019
April 16-17, 2019 - InterContinental Shanghai Ruijin Hotel, Shanghai, China
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies

Jefferies 6th Annual IO Cell Therapy Summit
April 5, 2019 - Boston Harbor Hotel, Boston, MA
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies

William Blair 9th Annual Cancer Immunotherapy Conference
March 20-21, 2019 - Apella Event Space Alexandria Center, New York, NY
ARTEMIS™ Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies

Clinical Application of CAR T Cells 2019
March 14-15, 2019 - Zuckerman Research Center, New York, NY
Development of ARTEMIS™ Antibody-TCR (AbTCR) Expressing T Cells Against Solid and Hematological Malignancies with the Potential to Eliminate CRS Risks

Cowen 39th Annual Health Care Conference
March 11-13, 2019 - Boston Marriott Copley Place, Boston, MA
A Novel T-Cell Engineering Technology (ARTEMIS™) for Strong Clinical Efficacy while Mitigating CRS/Neurotoxicity

CAR-TCR Summit
September 4-7, 2018 – Boston, MA United States
Overcoming Safety Challenges of Genetically Engineered T-Cell Therapy for the Treatment of Cancer

ASCO Annual Meeting
June 1-5, 2018 – McCormick Place, Chicago, Illinois
ET190L1-ARTEMIS™ T cell therapy leads to complete remission of relapsed and refractory (r/r) B-cell lymphoma with no cytokine release syndrome in the first-in-human clinical study

AACR Annual Meeting
April 14-18, 2018 – McCormick Place North/South, Chicago, Illinois
Anti-CD19 ARTEMIS™ T cells prevent excessive inflammatory cytokine release, including IL-6, in a co-culture model of CRS

World Adopt Summit 2017
March 7-9, 2017 – London, United Kingdom
Targeting the "Untargetable" Solid Tumor Antigens

ASH Annual Meeting
December 3-6, 2016 – San Diego, CA United States
Anti-CD19-ARTEMIS™ T cell therapy reduces cytokine release without compromising efficacy against preclinical lymphoma models

CAR-TCR Summit
September 13-16, 2016 – Boston, MA United States
TCR-like CARs targeting intracellular cancer-specific antigens for treatment of solid tumors

Immuno Oncology Summit - Adoptive T Cell Therapy
September 1-2, 2016 – Boston, MA United States
Bispecific T-Cell Engaging Antibody Targeting AFP/MHC Complex for the Treatment of Liver Cancer

CBIS 11th Biennial Conference
July 29-August 2, 2016 – Chengdu, China
Innovating antibody and adoptive T-cell therapies for targeting “undruggable” cancer antigens

June 3-7, 2016 – Chicago, IL United States
Towards a safer CD19 CAR-T therapy with reduced risk of Cytokine Release Syndrome (CRS)

5th Annual Cell Line Development & Engineering Asia Conference
May 17-19, 2016 – Shanghai, China
Assessment of antibody- or cell- mediated cytotoxicity via multiple assay platforms

April 16-20, 2016 – New Orlean, LA United States
ET1402L1-CAR-T therapy targeting alpha-fetoprotein (AFP)-MHCI complex for liver cancer

CAR-T Summit
November 12-13, 2015 – Cambridge, MA United States
First-in-class CAR-T therapy for HCC via targeting an AFP-MHCI complex

4th Annual Cell Line Development & Engineering Asia Conference
May 19-22, 2015 – Shanghai, China
Assessment of antibody Fc mediated effector functions via multiple assay platforms